WJ, M., ZQ, L., JZ, H., ZG, H., ZF, Z., JH, C., . . . ZB, F. (2024). Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq. The International journal of biological markers, 39(2), 168. https://doi.org/10.1177/03936155241238759
Chicago Style (17th ed.) CitationWJ, Mo, Liang ZQ, Huang JZ, Huang ZG, Zhi ZF, Chen JH, Chen G, Zeng JJ, and Feng ZB. "Clinicopathological Role of Cyclin A2 in Uterine Corpus Endometrial Carcinoma: Integration of Tissue Microarrays and ScRNA-Seq." The International Journal of Biological Markers 39, no. 2 (2024): 168. https://doi.org/10.1177/03936155241238759.
MLA (9th ed.) CitationWJ, Mo, et al. "Clinicopathological Role of Cyclin A2 in Uterine Corpus Endometrial Carcinoma: Integration of Tissue Microarrays and ScRNA-Seq." The International Journal of Biological Markers, vol. 39, no. 2, 2024, p. 168, https://doi.org/10.1177/03936155241238759.